In the Litigation Daily article by Julie Triedman, "Supreme Court of Canada Rules for GlaxoSmithKline in Transfer-Pricing Case", Claire Kennedy comments on the Supreme Court decision that the Canadian government had to take into account more than just the narrow market price of a product when assessing whether GlaxoSmithKline's transfer pricing was reasonable.
In The News
Claire Kennedy in the Litigation Daily on GlaxoSmithKline Transfer-Pricing Case
December 14, 2012
Republishing Requests
For permission to republish this or any other publication, contact Peter Zvanitajs at ZvanitajsP@bennettjones.com.
For informational purposes only
This publication provides an overview of legal trends and updates for informational purposes only. For personalized legal advice, please contact the authors.
Latest Insights
See All Insights
Blog
& 1 more
Better Early Than Sorry: Strict Compliance Required for Lien Deadlines
November 27, 2025
Blog
Ahmed Elmallah, Lorelei Graham & Edward (Ted) Yoo
X.AI Corp. v. OpenAI—Why Every Business (and Start-Up) Needs an Employee Governance Policy for Managing Confidential Business Information and IP Risk
November 21, 2025